ArticleActa neuropathologica communications2017

The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease.

David I Finkelstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.